Balancing procedural safety and therapeutic continuity: GLP‐1 receptor agonists and upper endoscopy

Documenti analoghi

• Glucagon‐like peptide‐1 receptor agonists and upper endoscopy: a real‐world experience
  di: Pichamol Jirapinyo, et al.
  Pubblicazione: (2025)
• Digital engagement enhances dual GIP / GLP ‐1 receptor agonist and GLP ‐1 receptor agonist efficacy: A retrospective cohort analysis of a digital weight loss service on outcomes and safety
  di: Hans Johnson, et al.
  Pubblicazione: (2025)
• Effectiveness and safety of GLP ‐1 receptor agonists in craniopharyngioma patients with obesity: A multicentre real‐world study
  di: Flora Lambert, et al.
  Pubblicazione: (2025)
• GLP‐1 receptor agonists and retained gastric content: Is it much ado about nothing?
  di: Michael Camilleri
  Pubblicazione: (2025)
• Less frequent dosing of GLP‐1 receptor agonists as a viable weight maintenance strategy
  di: Calvin C. Wu, et al.
  Pubblicazione: (2025)